| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/03/2000 | WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 08/03/2000 | WO2000024412A3 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| 08/03/2000 | WO2000023471A3 Use of a cytokine-producing lactococcus strain to treat colitis |
| 08/03/2000 | WO2000006589A9 Prostate derived ets factor |
| 08/03/2000 | WO2000005208A9 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof |
| 08/03/2000 | CA2361553A1 Antibodies specific to kdr and uses thereof |
| 08/03/2000 | CA2361260A1 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions |
| 08/03/2000 | CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers |
| 08/03/2000 | CA2359034A1 Pyrazino(aza)indole derivatives |
| 08/03/2000 | CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2355735A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors |
| 08/02/2000 | EP1023324A1 Trivalent thrombin inhibitor |
| 08/02/2000 | EP1023295A1 Fibrinogen receptor antagonist prodrugs |
| 08/02/2000 | EP1023282A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 08/02/2000 | EP1023274A1 An efficient method for the conversion of nitriles to amidines |
| 08/02/2000 | EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 08/02/2000 | EP1023067A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 08/02/2000 | EP1023066A1 Novel pyrazole and pyrazoline substituted compounds |
| 08/02/2000 | EP0691953B1 1-amidinophenyl-pyrrolidones/ piperidinones as platelet aggregation inhibitors |
| 08/02/2000 | EP0554383B1 Blood coagulation protein antagonists and uses therefor |
| 08/02/2000 | CN1261895A Cyclic azapeptide with angiogenic effect |
| 08/02/2000 | CN1054999C Multiple effect enriching blood oral liquor |
| 08/01/2000 | US6096877 Cdna sequences coding a protein with inhibitory activity |
| 08/01/2000 | US6096753 Substituted pyrimidinone and pyridone compounds and methods of use |
| 08/01/2000 | US6096735 Benzoheterocyclic derivatives |
| 08/01/2000 | US6096707 Cyclic oligo/polypeptide including an arginine-lysine-lysine-histidine sequence effective to inhibit integrin-dependent cell migration |
| 08/01/2000 | US6096309 Compositions containing thrombin and microfibrillar nanometer collagen, and methods for preparation and use thereof |
| 08/01/2000 | CA2199832C Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 08/01/2000 | CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/01/2000 | CA2149209C Use of topically applied factor xiii for inhibiting hemorrhage |
| 08/01/2000 | CA2026036C Sulphated glycosamino glycuronan with antithrombotic activity |
| 07/27/2000 | WO2000043524A1 Polypeptides derived from jnk3 |
| 07/27/2000 | WO2000043498A2 Human liver progenitors |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043395A1 Substituted porphyrins |
| 07/27/2000 | WO2000043378A1 New morpholinobenzamide salts |
| 07/27/2000 | WO2000043373A2 Kinase inhibitors |
| 07/27/2000 | WO2000043372A1 Acyl derivatives which treat vla-4 related disorders |
| 07/27/2000 | WO2000043369A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043042A1 Parenteral metolazone formulations |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000043020A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | WO2000043019A2 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | WO2000043003A1 The therapeutic use of r-warfarin as anticoagulant |
| 07/27/2000 | WO2000027998A3 Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 07/27/2000 | WO2000023588A3 G-protein coupled receptors |
| 07/27/2000 | WO2000023567A3 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 07/27/2000 | WO2000023086A3 Buffered compositions for dialysis |
| 07/27/2000 | WO2000017375A3 Method to treat haemophilia by in vivo gene therapy with retroviral vectors |
| 07/27/2000 | WO2000017328A3 Fibrils |
| 07/27/2000 | WO2000012683A9 Stem cells bearing an fgf receptor on the cell surface |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2360730A1 Human liver progenitors |
| 07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359105A1 New morpholinobenzamide salts |
| 07/27/2000 | CA2358914A1 Polypeptides derived from jnk3 |
| 07/27/2000 | CA2355168A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/26/2000 | EP1021549A2 SENSE mRNA THERAPY |
| 07/26/2000 | EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP1021401A1 Calcitriol derivatives and their uses |
| 07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 07/26/2000 | EP1021181A1 Carboxylic acid indole inhibitors of chemokines |
| 07/26/2000 | EP1021134A1 Use of hemoglobin to prevent sepsis or treat systemic inflammatory response syndrome |
| 07/26/2000 | EP1021087A1 Serotonin containing formulation for oral administration and method of use |
| 07/26/2000 | EP0796245B1 Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs |
| 07/26/2000 | EP0643583B1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 07/26/2000 | CN1261352A New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists |
| 07/26/2000 | CN1261285A CD 154 blockade therapy for therapeutic protein inhibitor syndrome |
| 07/26/2000 | CN1261282A Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins |
| 07/26/2000 | CN1261280A Improved methods for processing activated protein C |
| 07/26/2000 | CN1261277A Novel substituted imidazole compounds |
| 07/26/2000 | CN1261274A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them. |
| 07/26/2000 | CN1054842C 1-amidinophenyl-pyrrolidones piperidinones azetinones platelet aggregation inhibitors |
| 07/26/2000 | CN1054750C Compound garlic oil capsule and its producing method |
| 07/26/2000 | CN1054746C Method for application of copper slicylacetate |
| 07/26/2000 | CN1054743C Argatroban consentrated aqueous solution |
| 07/25/2000 | US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 07/25/2000 | US6093743 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/25/2000 | US6093717 Imidazopyridine thrombin inhibitors |
| 07/25/2000 | US6093561 Human lysophospholipase |
| 07/25/2000 | US6093531 Generation of hematopoietic cells from multipotent neural stem cells |
| 07/25/2000 | US6093399 Specific blood coagulation exemplified by in vivo coagulation of tumor vasculature, causing tumor regression, through the site-specific delivery of a coagulant using a bispecific antibody |
| 07/20/2000 | WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | WO2000042179A2 Complex-forming proteins |
| 07/20/2000 | WO2000042175A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | WO2000042073A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | WO2000042059A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 07/20/2000 | WO2000042011A1 Amide compounds |
| 07/20/2000 | WO2000041727A1 Transcutaneous photodynamic treatment of targeted cells |
| 07/20/2000 | WO2000041716A1 New use of melagatran |
| 07/20/2000 | WO2000041715A1 New dialysis method |
| 07/20/2000 | WO2000041705A1 Pre-conditioning against cell death |